These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 33987916)
1. Are drug prices subject to creative destruction? Evidence from the US, 1997-2017. Lichtenberg FR Health Econ; 2021 Aug; 30(8):1910-1932. PubMed ID: 33987916 [TBL] [Abstract][Full Text] [Related]
2. Association of Generic Competition With Price Decreases in Physician-Administered Drugs and Estimated Price Decreases for Biosimilar Competition. Dickson SR; Kent T JAMA Netw Open; 2021 Nov; 4(11):e2133451. PubMed ID: 34779844 [TBL] [Abstract][Full Text] [Related]
3. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS. Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194 [TBL] [Abstract][Full Text] [Related]
4. The effect of generic competition on the price of brand-name drugs. Lexchin J Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552 [TBL] [Abstract][Full Text] [Related]
5. Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition. Zhang JX PLoS One; 2020; 15(6):e0234463. PubMed ID: 32525965 [TBL] [Abstract][Full Text] [Related]
6. Effect of Competition on Generic Drug Prices. Nguyen NX; Sheingold SH; Tarazi W; Bosworth A Appl Health Econ Health Policy; 2022 Mar; 20(2):243-253. PubMed ID: 34904207 [TBL] [Abstract][Full Text] [Related]
7. Generic script share and the price of brand-name drugs: the role of consumer choice. Rizzo JA; Zeckhauser R Int J Health Care Finance Econ; 2009 Sep; 9(3):291-316. PubMed ID: 19130220 [TBL] [Abstract][Full Text] [Related]
8. Product-line extensions and pricing strategies of brand-name drugs facing patent expiration. Hong SH; Shepherd MD; Scoones D; Wan TT J Manag Care Pharm; 2005; 11(9):746-54. PubMed ID: 16300418 [TBL] [Abstract][Full Text] [Related]
9. The Impact of Generic Entry of Pharmaceuticals in Australia. Jones AM; Serra-Sastre V; Kim H Value Health Reg Issues; 2024 Sep; 43():101008. PubMed ID: 38925096 [TBL] [Abstract][Full Text] [Related]
10. Reference pricing with endogenous generic entry. Brekke KR; Canta C; Straume OR J Health Econ; 2016 Dec; 50():312-329. PubMed ID: 27350294 [TBL] [Abstract][Full Text] [Related]
11. The Evolution of Supply and Demand in Markets for Generic Drugs. Frank RG; McGuire TG; Nason I Milbank Q; 2021 Sep; 99(3):828-852. PubMed ID: 34075623 [TBL] [Abstract][Full Text] [Related]
12. Competition and price among brand-name drugs in the same class: A systematic review of the evidence. Sarpatwari A; DiBello J; Zakarian M; Najafzadeh M; Kesselheim AS PLoS Med; 2019 Jul; 16(7):e1002872. PubMed ID: 31361747 [TBL] [Abstract][Full Text] [Related]
13. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs. Li DG; Joyce C; Mostaghimi A JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117 [TBL] [Abstract][Full Text] [Related]
14. Impact of European pharmaceutical price regulation on generic price competition: a review. Puig-Junoy J Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079 [TBL] [Abstract][Full Text] [Related]
15. Bib Pharma Monopoly: Why Consumers Keep Landing on "Park Place" and How the Game is Rigged. Levy MS Am Univ Law Rev; 2016; 66(1):247-303. PubMed ID: 28225582 [TBL] [Abstract][Full Text] [Related]
16. Price regulation and generic competition in the pharmaceutical market. Dalen DM; Strøm S; Haabeth T Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230 [TBL] [Abstract][Full Text] [Related]
17. Do pharmaceutical prices rise anticipating branded competition? Ellyson AM; Basu A Health Econ; 2021 May; 30(5):1070-1081. PubMed ID: 33684255 [TBL] [Abstract][Full Text] [Related]
18. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011. Cheng N; Banerjee T; Qian J; Hansen RA J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255 [TBL] [Abstract][Full Text] [Related]
19. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform. Kesselheim AS; Avorn J; Sarpatwari A JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619 [TBL] [Abstract][Full Text] [Related]
20. What do pharmaceuticals really cost in the long run? Lakdawalla D; MacEwan JP; Dubois R; Westrich K; Berdud M; Towse A Am J Manag Care; 2017 Aug; 23(8):488-493. PubMed ID: 29087143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]